This POC Biosensor Detects Oral Cancer

The point-of-care biosensor gives rapid results and is ideal for low resource and remote regions where conventional tests aren’t available.

Screenshot 2023 01 06 At 8 53 29 Am
University of Florida

Early detection of oral cancer is key for survival. It has been reported that localized oral cancers 2 cm or less in size can be treated easily with a five-year survival rate of over 90%. However, early detection requires accessibility to accurate diagnostics. According to a recent Medgadget article, University of Florida scientists have developed a point-of-care biosensor for the rapid detection of oral cancer. The testing device employs strips similar to those used in blood glucose tests to identify CIP2A, a protein biomarker that indicates the presence of oral cancer. 

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?